ArticlePloS one2025
Copper supplementation enhances pigmentation and induces dopamine production in ARPE19.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-neuronal dopamine production has not been understood despite dopamine function in non-neuronal tissues. Tyrosinase is a non-neuronal enzyme which converts tyrosine to L-DOPA (l-3,4-dihydroxyphenylalanine) and L-DOPA to l-dopaquinone for further melanin production. Since L-DOPA is a dopamine precursor in neurons, we hypothesized that tyrosinase-derived L-DOPA could alternatively be converted to dopamine. Therefore, this study investigated whether copper supplementation enhanced pigmentation and induced dopamine production via tyrosinase activation in APRE19 cells. Copper is known as a tyrosinase cofactor. In two separate experiments, we cultured ARPE19 in 1% FBS/DMEM with/without 10 μM copper sulfate for approximately 100 days. After 40-50 days, slight pigmentation with copper treatment was confirmed in the cell pellets, while no pigmentation was observed in the non-copper control. After 90-100 days, the pigmentation in the copper treatment group was obvious, while minimal pigmentation was observed in the non-copper control. Dopamine was not detected at 40-50 days in either group, while it was detected after 90-100 days of culture only in the copper-treated group. Tyrosinase mRNA expression was confirmed in both groups at a similar level, while tyrosinase protein expression was significantly higher in the copper treatment group than in the non-copper control. Thus, we determined that copper supplementation efficiently enhances pigmentation and induces dopamine production in long-term culture ARPE19, likely due to increased tyrosinase protein expression and activity. This is the first report showing the significance of copper in non-neuronal dopamine production of RPE cells, which suggests that tyrosinase may be responsible for non-neuronal dopamine production.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.